Related Experiment Video
Updated: Aug 8, 2026

11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Selamectin: a novel broad-spectrum endectocide for dogs and cats
B F Bishop1, C I Bruce, N A Evans
1Animal Health Discovery, Central Research Division, Pfizer Limited, Sandwich, Kent, UK. bernard-bishop@sandwich.pfizer.com
Veterinary Parasitology
|August 15, 2000
Summary
Selamectin is a new drug effective against fleas, ticks, and common intestinal parasites in dogs and cats. It is also safe for Collies, a breed sensitive to similar avermectin drugs.
Area of Science:
- Veterinary Pharmacology
- Parasitology
Background:
- Avermectins are widely used antiparasitic drugs.
- Some breeds, like Collies, exhibit sensitivity to avermectins.
- Novel endectocides with improved safety profiles are needed.
Purpose of the Study:
- To evaluate the efficacy and safety of selamectin in dogs and cats.
- To assess selamectin's tolerability in Collies.
Main Methods:
- Oral and topical administration of selamectin.
- Efficacy testing against fleas, ticks, hookworms, ascarids, and immature heartworms.
- Dosage-ranging safety studies in Collies.
Main Results:
- Selamectin demonstrated efficacy against a broad spectrum of parasites.
- The compound was well-tolerated following both administration routes.
- Collies tolerated higher selamectin dosages compared to other avermectins.
Conclusions:
- Selamectin is a novel endectocide with a favorable efficacy and safety profile for dogs and cats.
- Its safety in avermectin-sensitive breeds like Collies is a significant advantage.
Related Concept Videos
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

